Cite
HARVARD Citation
Gan, L. et al. (2019). Safety, tolerability, pharmacokinetics and effect on serum uric acid of the myeloperoxidase inhibitor AZD4831 in a randomized, placebo‐controlled, phase I study in healthy volunteers. British journal of clinical pharmacology. 85 (4), pp. 762-770. [Online].